Efficacy Analysis of Wandai Decoction Combined with Traditional Chinese Medicine Fumigation and Washing in Patients with Chronic Vaginitis After Sintilimab Treatment for Small Cell Lung Cancer

被引:1
|
作者
Wu, Yanjia [1 ]
Tang, Lin [1 ]
机构
[1] Hainan Med Univ, Hainan Affiliated Hosp, Hainan Gen Hosp, Dept Tradit Chinese Med, Haikou, Hainan, Peoples R China
关键词
D O I
暂无
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective center dot To investigate the effect of Wandai decoction combined with traditional Chinese medicine fumigation and washing in patients with chronic vaginitis after sintilimab treatment for small cell lung cancer. Methods center dot We recruited 80 patients who developed chronic vaginitis after sintilimab treatment for small cell lung cancer from Hainan General Hospital from January 2020 to June 2022; using a random number table, 40 were assigned to a control group and 40 were assigned to an observation group. The control group was treated with Wandai decoction, and the observation group was treated with Wandai decoction combined with traditional Chinese medicine fumigation and washing. The 2 groups were compared for improvement of the symptoms of vulvar pruritus subsidence time, leukorrhea recovery time, and traditional Chinese medicine symptom score; levels of the vaginal microecological environment factors immunoglobulin G, secretory immunoglobulin A, and pH; levels of the serum inflammatory factors C-reactive protein, tumor necrosis factor, and interleukin-6; and clinical efficacy. Results center dot After treatment, the observation group had significantly higher vulvar pruritus subsidence time, leukorrhea recovery time, traditional Chinese medicine symptom score, and pH value; significantly lower levels of C-reactive protein, tumor necrosis factor, and interleukin- 6; and significantly higher levels of immunoglobulin G, secretory immunoglobulin A, and total effective rate compared with the control group (all P < .0.001). Conclusions center dot Wandai decoction combined with traditional Chinese medicine fumigation and washing was effective in treating chronic vaginitis after sintilimab treatment for small cell lung cancer. The treatment ameliorated symptoms of leukorrhea abnormalities, vulvar pruritus, and local inflammation, and promoted the recovery of the vaginal microbial environment. Despite the limitations of our study (small sample size and lack of comparison between different types of chronic vaginitis, which hinders the confirmation of extensive efficacy), we consider Wandai decoction combined with traditional Chinese medicine fumigation and washing worthy of promotion and application in clinical practice.
引用
收藏
页码:268 / 273
页数:6
相关论文
共 50 条
  • [31] The effects of traditional Chinese medicine combined with chemotherapy on immune function and quality of life in patients with non-small cell lung cancer A protocol for systematic review and meta-analysis
    Zhao, Li-Na
    Yang, Yin-Qing
    Wang, Wen-Wen
    Li, Qian
    Xiao, Hua
    MEDICINE, 2020, 99 (45) : E22859
  • [32] EVALUATION OF EFFICACY AND SAFETY OF BEVACIZUMAB COMBINED WITH CHEMOTHERAPY FOR CHINESE PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Zhong, W.
    Zhang, L.
    Zhao, J.
    Wang, M-Z
    Li, L-Y
    RESPIROLOGY, 2011, 16 : 146 - 146
  • [33] Clinical Study on Treatment of Non-small Cell Lung Cancer by Chinese Herbal Medicine Combined with Bronchial Arterial Chemotherapy
    刘城林
    王远东
    金学军
    刘丽萍
    喻庆薇
    蔡悦成
    Chinese Journal of Integrated Traditional and Western Medicine, 2001, (04) : 242 - 246
  • [34] Efficacy of Endostar Combined with Chemotherapy and Endostar Maintenance Treatment for Patients with Extensive Small-Cell Lung Cancer
    Chen, Li
    Wu, Yongxin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S497 - S497
  • [35] Clinical study on treatment of non-small cell lung cancer by chinese herbal medicine combined with bronchial arterial chemotherapy
    Cheng-lin Liu
    Yuan-dong Wang
    Yuan-dong Jin
    Li-ping Liu
    Qing-wei Yu
    Yu-cheng Cai
    Chinese Journal of Integrated Traditional and Western Medicine, 2001, 7 (4): : 242 - 246
  • [36] Traditional Chinese Medicine Integrated with Chemotherapy for Stage II-IIIA Patients with Non-Small-Cell Lung Cancer after Radical Surgery: A Retrospective Clinical Analysis with Small Sample Size
    Zhao, Xueyu
    Dai, Xiaojun
    Wang, Shanshan
    Yang, Ting
    Yan, Yan
    Zhu, Guang
    Feng, Jun
    Pan, Bo
    Sunagawa, Masataka
    Zhang, Xiaochun
    Qian, Yayun
    Liu, Yanqing
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 2018
  • [37] EFFICACY OF ERLOTINIB FOR CNS RELAPSE AFTER GEFITINIB TREATMENT IN NON SMALL CELL LUNG CANCER PATIENTS
    Yanagitani, N.
    Sakatani, T.
    Saito, R.
    Tanaka, H.
    Kaburaki, K.
    Kudo, K.
    Ohyanagi, F.
    Horiike, A.
    Horai, T.
    Nishio, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 155 - 156
  • [38] Chinese herbal medicine for small cell lung cancer patients A protocol for a systematic review and meta-analysis
    Mi, Xue
    Zhang, Xiwen
    He, Shulin
    Zhang, Zhenhua
    Qi, Runzhi
    Jiang, Juling
    Chen, Shuntai
    Zheng, Honggang
    Hua, Baojin
    MEDICINE, 2020, 99 (52)
  • [39] Nomogram-based prognostic tool for stage IIIB/IV non-small cell lung cancer patients undergoing traditional Chinese medicine treatment
    Liu, Yihong
    Ma, Haochuan
    Zhou, Rui
    Chen, Yadong
    Zhu, Yanjuan
    Chang, Xuesong
    Chen, Jicai
    Zhang, Haibo
    HELIYON, 2024, 10 (10)
  • [40] Meta-analysis of the efficacy and safety of anlotinib combined with chemotherapy in the treatment of small cell lung cancer.
    Gao, Ting
    Zhao, Peiwen
    Li, Juanzhi
    Li, Yingjie
    Li, Xinxin
    He, Xiaopeng
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)